These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33343381)

  • 1. New Insights Into Implications of CTRP3 in Obesity, Metabolic Dysfunction, and Cardiovascular Diseases: Potential of Therapeutic Interventions.
    Guo B; Zhuang T; Xu F; Lin X; Li F; Shan SK; Wu F; Zhong JY; Wang Y; Zheng MH; Xu QS; Ehsan UMH; Yuan LQ
    Front Physiol; 2020; 11():570270. PubMed ID: 33343381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation.
    Li Y; Wright GL; Peterson JM
    Compr Physiol; 2017 Jun; 7(3):863-878. PubMed ID: 28640446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
    Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection.
    Yang Y; Li Y; Ma Z; Jiang S; Fan C; Hu W; Wang D; Di S; Sun Y; Yi W
    Prog Lipid Res; 2016 Oct; 64():170-177. PubMed ID: 27743997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q/TNF-related protein 3 expression and effects on adipocyte differentiation of 3T3-L1 cells.
    Nishimoto H; Yamamoto A; Furukawa S; Wakisaka S; Maeda T
    Cell Biol Int; 2017 Feb; 41(2):197-203. PubMed ID: 27590487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of hepatic gluconeogenesis and amino acid metabolism in CTRP3-deficient mice.
    Maeda T
    Mol Biol Rep; 2022 Feb; 49(2):1617-1622. PubMed ID: 34811637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases.
    Shanaki M; Shabani P; Goudarzi A; Omidifar A; Bashash D; Emamgholipour S
    Life Sci; 2020 Sep; 256():117913. PubMed ID: 32526287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the CTRP family in tumor development and progression.
    Kong M; Gao Y; Guo X; Xie Y; Yu Y
    Oncol Lett; 2021 Oct; 22(4):723. PubMed ID: 34429763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement c1q tumor necrosis factor-related protein 3 a novel adipokine, protect against diabetes mellitus in young adult Egyptians.
    Elsaid HH; Elgohary MN; Elshabrawy AM
    Diabetes Metab Syndr; 2019; 13(1):434-438. PubMed ID: 30641739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased CTRP3 Plasma Concentrations Are Associated with Sepsis and Predict Mortality in Critically Ill Patients.
    Yagmur E; Otto S; Koek GH; Weiskirchen R; Trautwein C; Koch A; Tacke F
    Diagnostics (Basel); 2019 Jun; 9(2):. PubMed ID: 31234326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function.
    Moradi N; Fadaei R; Khamseh ME; Nobakht A; Rezaei MJ; Aliakbary F; Vatannejad A; Hosseini J
    PLoS One; 2019; 14(4):e0215617. PubMed ID: 31009504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q/TNF-related protein-3 and glucose homeostasis.
    Yaribeygi H; Rashidfarrokhi F; Atkin SL; Sahebkar A
    Diabetes Metab Syndr; 2019; 13(3):1923-1927. PubMed ID: 31235116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance.
    Deng W; Li C; Zhang Y; Zhao J; Yang M; Tian M; Li L; Zheng Y; Chen B; Yang G
    Diabetol Metab Syndr; 2015; 7():33. PubMed ID: 25878729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
    Jaganathan R; Ravindran R; Dhanasekaran S
    Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.
    Yan Z; Zhao J; Gan L; Zhang Y; Guo R; Cao X; Lau WB; Ma X; Wang Y
    PLoS One; 2017; 12(6):e0178253. PubMed ID: 28632765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of C1q/TNF-Related Protein-3 (CTRP3) and CTRP13 Serum Levels with Coronary Artery Disease in Subjects with and without Type 2 Diabetes Mellitus.
    Fadaei R; Moradi N; Baratchian M; Aghajani H; Malek M; Fazaeli AA; Fallah S
    PLoS One; 2016; 11(12):e0168773. PubMed ID: 28033351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adiponectin paralog C1q/TNF-related protein 3 (CTRP3) stimulates testosterone production through the cAMP/PKA signaling pathway.
    Otani M; Kogo M; Furukawa S; Wakisaka S; Maeda T
    Cytokine; 2012 May; 58(2):238-44. PubMed ID: 22342437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of weight cycling on CTRP3 expression, adipose tissue inflammation and insulin sensitivity in C57BL/6J mice.
    Li X; Jiang L; Yang M; Wu YW; Sun JZ
    Exp Ther Med; 2018 Sep; 16(3):2052-2059. PubMed ID: 30186439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory roles of CTRP3 in endotoxemia and metabolic stress.
    Petersen PS; Wolf RM; Lei X; Peterson JM; Wong GW
    Physiol Rep; 2016 Mar; 4(5):. PubMed ID: 26997632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.